Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Conditions: Hypertension; Hyperlipidemias Interventions: Drug: Atorvastatin; Other: placebo Sponsor: Yale University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Heart | Hormonal Therapy | Hormones | Hypertension | Lipitor | Research | Statin Therapy | Zivast